Purpose: To evaluate the extraocular muscles involvement in Graves’ disease (GD) patients without signs of active Graves’ orbitopathy (GO). Patients were classified with Clinical Activity Score (CAS) proposed by EUropean Group of Graves' Orbitopathy. CAS is based on the presence of ocular symptoms: active lid swelling, eyelid erythema, definitive conjunctival redness, chemosis, caruncle or plical infiammation, spontaneous orbital pain, gaze evoked orbital pain. Methods: Sixty-four GD patients asymptomatic for active GO ( CAS ≤ 2) and spontaneous diplopia were studied. CAS classification of patients was represented by thirty-five with CAS 0 with no symptoms of GO, twenty-four patients CAS 1 presented only one GO symptom, and five patients...
Background. To examine factors contributing to extraocular muscle (EOM) volume enlargement in patien...
Graves’ disease is an autoimmune disorder in which hyperthyroidism results in various systematic sym...
Background: The overall changes of ocular motility in Graves' Orbitopathy (GO), are not easily quant...
Purpose: To evaluate the extraocular muscles involvement in Graves’ disease (GD) patients without si...
AIM: To evaluate the extraocular muscles involvement in Graves’ disease (GD) patients without signs ...
Purpose: To evaluate if specific subclinical ocular signs, in association with thyroid function and ...
PURPOSE: To describe the prevalence of fat and muscle volume (MV) increase in Graves' orbitopathy (G...
Introduction: Graves ophthalmopathy is an autoimmune disease, which is the consequence of thyroid dy...
PURPOSE: Ocular motility disturbances are common in patients with thyroid-associated ophthalmopathy ...
Purpose: To assess the effectiveness of the upper eyelid double motion sign in Graves’ orbitopathy (...
The aim of this study is to describe characteristics of Graves' orbitopathy (GO) patients with progr...
Graves' Hyperthyroidism (GH) is an autoimmune disease that affects 1 in every 100 Canadians accordi...
Purpose: Graves’ orbitopathy (GO) is a specific inflammatory disorder of the orbit characterized by ...
Background: Diplopia identifies patients with eye muscle involvement in Graves ’ ophthalmopathy (GO)...
INTRODUCTION Graves’ disease (GD) is an autoimmune disease affecting the thyroid gland, orbital sof...
Background. To examine factors contributing to extraocular muscle (EOM) volume enlargement in patien...
Graves’ disease is an autoimmune disorder in which hyperthyroidism results in various systematic sym...
Background: The overall changes of ocular motility in Graves' Orbitopathy (GO), are not easily quant...
Purpose: To evaluate the extraocular muscles involvement in Graves’ disease (GD) patients without si...
AIM: To evaluate the extraocular muscles involvement in Graves’ disease (GD) patients without signs ...
Purpose: To evaluate if specific subclinical ocular signs, in association with thyroid function and ...
PURPOSE: To describe the prevalence of fat and muscle volume (MV) increase in Graves' orbitopathy (G...
Introduction: Graves ophthalmopathy is an autoimmune disease, which is the consequence of thyroid dy...
PURPOSE: Ocular motility disturbances are common in patients with thyroid-associated ophthalmopathy ...
Purpose: To assess the effectiveness of the upper eyelid double motion sign in Graves’ orbitopathy (...
The aim of this study is to describe characteristics of Graves' orbitopathy (GO) patients with progr...
Graves' Hyperthyroidism (GH) is an autoimmune disease that affects 1 in every 100 Canadians accordi...
Purpose: Graves’ orbitopathy (GO) is a specific inflammatory disorder of the orbit characterized by ...
Background: Diplopia identifies patients with eye muscle involvement in Graves ’ ophthalmopathy (GO)...
INTRODUCTION Graves’ disease (GD) is an autoimmune disease affecting the thyroid gland, orbital sof...
Background. To examine factors contributing to extraocular muscle (EOM) volume enlargement in patien...
Graves’ disease is an autoimmune disorder in which hyperthyroidism results in various systematic sym...
Background: The overall changes of ocular motility in Graves' Orbitopathy (GO), are not easily quant...